Maolac

Developing antibodies and nutrients enriched preventive nutritional products.

placeJerusalem, Jerusalem District, Israel calendar_todayFounded 2020 groups19 employees language maolac.com

Innovation

1 patent family — focus: Human necessities; filing pace slowing. Cited 14 times.

YearFilings
20211
20221
20231

Social engagement

Social engagement: 4.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include OurCrowd.

Investor typeCountShare
Venture capital450%
Angel & family office113%
Accelerator & incubator113%
Other / undisclosed225%

Recent activity

16 Jun 2026
Event
ProbiotaAmericas 2026
8 Jun 2026
Event
Probiota Americas
1 Jun 2026
Event
Healthgevity Institute webinar following Colostrum-GI Bio-BioticTM launch
Coming soon